ChemoMetec A/S (CHEMM.CO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Martin Helbo Behrens
|
Chief Executive Officer | 5.1M | -- | 1992 |
|
Mr. Phillip Massie Price
|
Chief Financial Officer | -- | -- | 1992 |
|
Mr. Bo Melholt Nielsen
|
Chief Technology & Automation Officer | -- | -- | -- |
|
Mr. Christopher Runchel M.Sc., Ph.D.
|
Chief Sales Officer | -- | -- | -- |
|
Mr. Søren Kjærulff
|
Head of R&D | -- | -- | -- |
|
Emil Sondergaard
|
Chief Commercial Officer | -- | -- | -- |
ChemoMetec A/S
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 174
Description
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
Corporate Governance
Upcoming Events
September 10, 2026 at 3:00 PM UTC
ChemoMetec A/S Earnings Date
Recent Events
October 10, 2025 at 12:00 AM UTC
Ex-Dividend Date
